compugroup medical se & co. kgaa - CMPVF

CMPVF

Close Chg Chg %
23.85 9.81 41.11%

Closed Market

33.66

+9.81 (41.11%)

Volume: 200.00

Last Updated:

Jan 15, 2026, 9:39 AM EDT

Company Overview: compugroup medical se & co. kgaa - CMPVF

CMPVF Key Data

Open

$30.15

Day Range

30.15 - 33.66

52 Week Range

22.50 - 33.66

Market Cap

$1.62B

Shares Outstanding

51.73M

Public Float

8.18M

Beta

0.95

Rev. Per Employee

N/A

P/E Ratio

80.89

EPS

$0.39

Yield

17.10%

Dividend

$0.06

EX-DIVIDEND DATE

Aug 4, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

CMPVF Performance

No Data Available

CMPVF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About compugroup medical se & co. kgaa - CMPVF

CompuGroup Medical SE & Co. KGaA engages in the provision of e-Health solutions. Its software products are designed to support all medical and organizational activities in doctor’s office, pharmacies, laboratories and hospitals. It operates through the following segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), and Hospital Information Systems (HIS). The AIS segment includes developing and selling practice management software for registered physicians, medical care centers and physician networks. The PCS segment t focuses on developing and selling integrated administrative and billing-related software applications for pharmacies. The HIS segment handles clinical and administrative solutions for the inpatient sector, where health services are provided over a prolonged period of time through highly specialized, secondary care institutions. The company was founded by Frank Gotthardt in 1987 and is headquartered in Koblenz, Germany.

CMPVF At a Glance

CompuGroup Medical SE & Co. KGaA
Maria Trost 21
Koblenz, Rheinland-Pfalz 56070
Phone 49-261-8000-0 Revenue 1.25B
Industry Services to the Health Industry Net Income 37.43M
Sector Health Services Employees 8,712
Fiscal Year-end 12 / 2025
View SEC Filings

CMPVF Valuation

P/E Current 80.895
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 31.23
Price to Sales Ratio 0.953
Price to Book Ratio 1.738
Price to Cash Flow Ratio 8.53
Enterprise Value to EBITDA 9.14
Enterprise Value to Sales 1.594
Total Debt to Enterprise Value 0.458

CMPVF Efficiency

Revenue/Employee 143,280.196
Income Per Employee 4,295.971
Receivables Turnover 4.894
Total Asset Turnover 0.578

CMPVF Liquidity

Current Ratio 1.188
Quick Ratio 1.144
Cash Ratio 0.324

CMPVF Profitability

Gross Margin 25.111
Operating Margin 7.766
Pretax Margin 5.432
Net Margin 2.998
Return on Assets 1.733
Return on Equity 5.315
Return on Total Capital 2.366
Return on Invested Capital 2.428

CMPVF Capital Structure

Total Debt to Total Equity 135.819
Total Debt to Total Capital 57.595
Total Debt to Total Assets 42.936
Long-Term Debt to Equity 127.554
Long-Term Debt to Total Capital 54.09
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Compugroup Medical Se & Co. Kgaa - CMPVF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.21B 1.19B 1.28B 1.25B
Sales Growth
+26.97% -2.03% +8.14% -2.78%
Cost of Goods Sold (COGS) incl D&A
874.00M 872.94M 960.92M 934.81M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
130.86M 118.05M 125.19M 120.77M
Depreciation
44.72M 44.95M 43.07M 46.48M
Amortization of Intangibles
86.14M 73.10M 82.12M 74.29M
COGS Growth
+38.09% -0.12% +10.08% -2.72%
Gross Income
337.91M 314.38M 323.08M 313.45M
Gross Income Growth
+5.10% -6.96% +2.77% -2.98%
Gross Profit Margin
+27.88% +26.48% +25.16% +25.11%
2021 2022 2023 2024 5-year trend
SG&A Expense
213.88M 190.62M 171.86M 227.77M
Research & Development
146.09M 111.61M 272.62M 275.90M
Other SG&A
67.78M 79.01M (100.75M) (48.13M)
SGA Growth
+25.81% -10.87% -9.84% +32.53%
Other Operating Expense
(21.38M) (9.35M) (16.53M) (11.26M)
Unusual Expense
27.84M 19.67M 72.75M 3.05M
EBIT after Unusual Expense
117.58M 113.44M 95.00M 93.89M
Non Operating Income/Expense
7.61M 11.67M 13.16M 13.18M
Non-Operating Interest Income
700.91K 606.41K 981.65K 1.05M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
9.54M 12.74M 30.26M 39.25M
Interest Expense Growth
+10.40% +33.49% +137.60% +29.70%
Gross Interest Expense
10.50M 14.33M 33.15M 42.07M
Interest Capitalized
959.77K 1.60M 2.89M 2.82M
Pretax Income
115.65M 112.36M 77.89M 67.81M
Pretax Income Growth
-8.90% -2.84% -30.68% -12.94%
Pretax Margin
+9.54% +9.46% +6.07% +5.43%
Income Tax
34.09M 34.37M 27.89M 29.35M
Income Tax - Current - Domestic
17.20M 12.94M 13.68M 5.15M
Income Tax - Current - Foreign
24.62M 21.06M 22.37M 25.02M
Income Tax - Deferred - Domestic
(7.73M) 370.99K (8.15M) (817.76K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
81.59M 77.90M 50.67M 37.60M
Minority Interest Expense
73.28K 741.99K 1.03M 173.07K
Net Income
81.52M 77.15M 49.64M 37.43M
Net Income Growth
-2.30% -5.36% -35.66% -24.60%
Net Margin Growth
+6.73% +6.50% +3.87% +3.00%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
81.52M 77.15M 49.64M 37.43M
Preferred Dividends
- - - -
-
Net Income Available to Common
81.52M 77.15M 49.64M 37.43M
EPS (Basic)
1.5578 1.477 0.9503 0.7215
EPS (Basic) Growth
+0.32% -5.19% -35.66% -24.08%
Basic Shares Outstanding
52.33M 52.23M 52.23M 51.87M
EPS (Diluted)
1.539 1.4755 0.9463 0.709
EPS (Diluted) Growth
-0.89% -4.13% -35.87% -25.08%
Diluted Shares Outstanding
52.97M 52.29M 52.45M 52.78M
EBITDA
276.27M 251.15M 292.94M 217.71M
EBITDA Growth
+14.06% -9.09% +16.64% -25.68%
EBITDA Margin
+22.80% +21.15% +22.81% +17.44%

Compugroup Medical Se & Co. Kgaa in the News